Navigation Links
China-Biotics, Inc. Announces the Results of the 2010 Annual Meeting of Stockholders
Date:3/14/2011

Inc. ("China-Biotics" or "the Company"), a leading manufacturer of biotechnology products and supplements, engages in the research, development, marketing and distribution of probiotics dietary supplements in China. Through its wholly owned subsidiaries, Shanghai Shining Biotechnology Co., Ltd. and Growing Bioengineering (Shanghai) Co. Ltd., the Company develops and produces a proprietary product portfolio. Currently, its retail products are sold over the counter, mainly through large distributors, to pharmacies and supermarkets in Beijing, Shanghai, and Jiangsu and Zhejiang provinces. The Company also sells bulk products to institutional customers such as dairy and animal feed producers as well as pharmaceutical companies. In February 2010, China-Biotics began its commercial production in China's largest probiotics production facility to meet the growing demand in China. For more information, please visit http://www.chn-biotics.com.Contact:Travis Cai Chief Financial OfficerChina-Biotics, Inc.traviscai@chn-biotics.comir@chn-biotics.comShiwei Yin/Dixon Chen Grayling646-284-9474shiwei.yin@grayling.comdixon.chen@grayling.com
'/>"/>
SOURCE China-Biotics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. China-Biotics, Inc. Reports Record Quarterly Net Sales for the Third quarter of Fiscal Year 2011
2. China-Biotics, Inc. Comments on Market Rumors
3. China-Biotics, Inc. Announces US$20 million Share Buyback Program
4. China-Biotics, Inc. to Hold 2009 Annual Meeting of Stockholders on March 5, 2010
5. China-Biotics, Inc. Begins Trial Production at New Facility, Affirms 2010 Revenue Guidance
6. China-Biotics, Inc. Prices $69 Million Public Offering of Common Stock
7. Watson Announces Favorable District Court Ruling in Generic Fentora® Patent Suit
8. Biodel Announces Accelerated Development Plan for Ultra-Rapid-Acting Insulins: Initiate Phase 2 in 2011; Phase 3 Pivotal Trials in 2012
9. Nephros Announces Completion of Reverse Stock Split
10. Arena Pharmaceuticals Announces Fourth Quarter and Full Year 2010 Financial Results and Reviews Recent Developments
11. Nephros Announces Completion of $3.2 Million Financing Through Rights Offering and Private Placement Transactions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2014)... Concord Medical Services Holdings Limited ("Concord Medical" ... leading specialty hospital management solution provider and operator of ... in China , today announced that ... a special cash dividend of US$0.30 per ordinary share ... Company,s outstanding ordinary shares. The total expense for the ...
(Date:7/28/2014)... July 28, 2014   Cardioxyl Pharmaceuticals, Inc. ... demonstrating that CXL-1427, a novel potential treatment for acute ... volunteers. The company has now initiated dosing of hospitalized ... clinical trial designed to further evaluate the drug,s safety ... The Phase I clinical trial evaluated the safety ...
(Date:7/28/2014)...  Isis Pharmaceuticals, Inc. (NASDAQ: ISIS ) ... Results and Highlights Conference CallWhen:Monday, August 4 at 10:30 ... on the Internet. Simply log onto our website listed ... live event, a replay of the webcast will be ... ABOUT ISIS PHARMACEUTICALS, INC. Isis is exploiting ...
Breaking Medicine Technology:Concord Medical Declares Special Dividend 2Cardioxyl Pharmaceuticals Successfully Completes First Clinical Trial For Heart Failure Drug CXL-1427 2Webcast Alert: Isis Pharmaceuticals' Second Quarter 2014 Financial Results Conference Call 2
... (NASDAQ: AMGN ) reported total revenue increased 3 ... versus $3,841 million in the fourth quarter of 2010.  For ... $15,582 million from $15,053 million in 2010. Adjusted ... of 2011, an increase of 3 percent compared to $1.17 ...
... Jan. 26, 2012 With increasing public scrutiny and ... the initiative to ensure they are protecting the health ... Medical Systems , a leading manufacturer of medical devices, ... to understand the chemical composition of its products, enabling ...
Cached Medicine Technology:Amgen's Full Year 2011 Revenue Increased 4 Percent to $15.6 Billion and Adjusted Earnings Per Share (EPS) Increased 2 Percent to $5.33 2Amgen's Full Year 2011 Revenue Increased 4 Percent to $15.6 Billion and Adjusted Earnings Per Share (EPS) Increased 2 Percent to $5.33 3Amgen's Full Year 2011 Revenue Increased 4 Percent to $15.6 Billion and Adjusted Earnings Per Share (EPS) Increased 2 Percent to $5.33 4Amgen's Full Year 2011 Revenue Increased 4 Percent to $15.6 Billion and Adjusted Earnings Per Share (EPS) Increased 2 Percent to $5.33 5Amgen's Full Year 2011 Revenue Increased 4 Percent to $15.6 Billion and Adjusted Earnings Per Share (EPS) Increased 2 Percent to $5.33 6Amgen's Full Year 2011 Revenue Increased 4 Percent to $15.6 Billion and Adjusted Earnings Per Share (EPS) Increased 2 Percent to $5.33 7Amgen's Full Year 2011 Revenue Increased 4 Percent to $15.6 Billion and Adjusted Earnings Per Share (EPS) Increased 2 Percent to $5.33 8Amgen's Full Year 2011 Revenue Increased 4 Percent to $15.6 Billion and Adjusted Earnings Per Share (EPS) Increased 2 Percent to $5.33 9Amgen's Full Year 2011 Revenue Increased 4 Percent to $15.6 Billion and Adjusted Earnings Per Share (EPS) Increased 2 Percent to $5.33 10Amgen's Full Year 2011 Revenue Increased 4 Percent to $15.6 Billion and Adjusted Earnings Per Share (EPS) Increased 2 Percent to $5.33 11Amgen's Full Year 2011 Revenue Increased 4 Percent to $15.6 Billion and Adjusted Earnings Per Share (EPS) Increased 2 Percent to $5.33 12Amgen's Full Year 2011 Revenue Increased 4 Percent to $15.6 Billion and Adjusted Earnings Per Share (EPS) Increased 2 Percent to $5.33 13Amgen's Full Year 2011 Revenue Increased 4 Percent to $15.6 Billion and Adjusted Earnings Per Share (EPS) Increased 2 Percent to $5.33 14Amgen's Full Year 2011 Revenue Increased 4 Percent to $15.6 Billion and Adjusted Earnings Per Share (EPS) Increased 2 Percent to $5.33 15Amgen's Full Year 2011 Revenue Increased 4 Percent to $15.6 Billion and Adjusted Earnings Per Share (EPS) Increased 2 Percent to $5.33 16Amgen's Full Year 2011 Revenue Increased 4 Percent to $15.6 Billion and Adjusted Earnings Per Share (EPS) Increased 2 Percent to $5.33 17Amgen's Full Year 2011 Revenue Increased 4 Percent to $15.6 Billion and Adjusted Earnings Per Share (EPS) Increased 2 Percent to $5.33 18Amgen's Full Year 2011 Revenue Increased 4 Percent to $15.6 Billion and Adjusted Earnings Per Share (EPS) Increased 2 Percent to $5.33 19Varian Medical Systems Uses SAP to Support Sustainability and Compliance With REACH and RoHS 2Varian Medical Systems Uses SAP to Support Sustainability and Compliance With REACH and RoHS 3Varian Medical Systems Uses SAP to Support Sustainability and Compliance With REACH and RoHS 4Varian Medical Systems Uses SAP to Support Sustainability and Compliance With REACH and RoHS 5
(Date:7/28/2014)... (PRWEB) July 28, 2014 Camp ... a new camp property in Cornville, AZ. The ... ill children with the opportunity to attend medically ... and families. The organization offers a variety of ... with chronic and life threatening illnesses including: Illness ...
(Date:7/28/2014)... Quincy Bioscience, makers of the nation’s leading memory ... release of the fourth edition of The Brain Health ... , The Brain Health Guide is a unique resource ... to improve memory and promote optimal aging. Rather than ... Guide provides ways to help minimize common memory lapses ...
(Date:7/28/2014)... HealthDay Reporter MONDAY, July ... just milliseconds to look at someone,s face and judge them ... that certain facial features seem to trigger specific first impressions ... of the mouth, for example, appear directly linked to whether ... The study findings suggest that first impressions are ...
(Date:7/28/2014)... TX (PRWEB) July 28, 2014 Ticket ... vs. AS Roma tickets in Dallas, TX at the ... July 24th in the USA and it is an eight ... from around the world including teams from La Liga, Serie ... teams that will battle it out on the pitch include: ...
(Date:7/28/2014)... (PRWEB) July 28, 2014 Glutamine is ... and it’s considered to be conditionally essential during times ... is an advanced recovery & Immune System Support. , ... glutamine your body produces, supplementing with additional glutamine may ... waste products in the body, digestion and immune system ...
Breaking Medicine News(10 mins):Health News:Camp Soaring Eagle Announces New Camp Site 2Health News:Camp Soaring Eagle Announces New Camp Site 3Health News:Quincy Bioscience Launches the Fourth Edition of The Brain Health Guide 2Health News:Facial Dimensions May Be Key to First Impressions 2Health News:Facial Dimensions May Be Key to First Impressions 3Health News:Real Madrid vs. AS Roma Tickets Cotton Bowl Dallas, TX: Ticket Down Cuts Ticket Prices for AS Roma vs. Real Madrid International Champions Cup Tickets 2Health News:Real Madrid vs. AS Roma Tickets Cotton Bowl Dallas, TX: Ticket Down Cuts Ticket Prices for AS Roma vs. Real Madrid International Champions Cup Tickets 3Health News:Betancourt Nutrition Introduces Glutamine Plus with Sustamine® L-Alanyl-L-Glutamine 2Health News:Betancourt Nutrition Introduces Glutamine Plus with Sustamine® L-Alanyl-L-Glutamine 3
... the blood is not associated with a reduced risk ... online May 27 in the Journal of the ... high doses of vitamin D may reduce the risk ... the relationship have reported inconsistent results. , In a ...
... finds evidence of slight link between higher concentrations, aggressive ... Men with a high blood concentration of vitamin D ... Cancer Institute researchers report. , Previous laboratory studies had ... prostate cancer risk, but epidemiological studies of that association ...
... Researchers have uncovered a completely unexpected way that the brain ... protective protein to nearby neurons. , Astrocytes are a type ... one of their roles is to chew up damaged nerves ... damaged area. , Roger Chung and colleagues have now ...
... higher in low-expenditure areas than in high-expenditure ones, study ... levels of spending on medical care don,t improve patients, ... who conducted a survey of Medicare beneficiaries. , Per ... United States and differences in health don,t account for ...
... review suggests they may help cancer cells resist chemo, ... new review of existing research suggests that cancer patients ... of antioxidants. , Although multivitamins may be all right ... or E supplements can spell trouble, said review author ...
... Environmentally friendly is not a phrase normally used to ... discovery at Tel Aviv University, the chemical industry is ... Arkadi Vigalok from the School of Chemistry at Tel ... to make certain steps of a complicated chain of ...
Cached Medicine News:Health News:No association found between vitamin D concentration in blood and risk of prostate cancer 2Health News:Vitamin D Status Not Associated With Lower Prostate Risk 2Health News:Spending Doesn't Improve Patients' Perception of Care 2Health News:Cancer Patients Should Steer Clear of Antioxidants 2Health News:Cancer Patients Should Steer Clear of Antioxidants 3Health News:1 small step for a lab science, 1 green leap for mankind 2
Inquire...
... a powerful PTFE membrane vacuum pump designed to ... Ideally suited for use with up to two ... instruments including vacuum ovens, concentrators, gel dryers, and ... PEEK head resistant to chemicals and heat load ...
... pumps deliver critical performance for all vacuum ... optimizes pump performance to suit all applications. ... convenient checking of proper oil levels at ... is designed to work with all Thermo ...
... two-stage, oil-sealed, rotary vane vacuum pumps specifically ... pump comes complete with a GBORK (Gas ... Mist Filter (EMF-10). The GBORK allows the ... keep the oil clean without losing oil. ...
Medicine Products: